Index test:The number of lesions and different PET metabolic parameters (SUVmax, etc.) in the area of interest were compared between the total body PET/CT of all patients.

4 trials

Sponsors

Department of Nuclear Medicine, First Medical Center, PLA General Hospital, First Medical Center, PLA General Hospital

Conditions

Prostate cancerneuroendocrine tumorurothelium carcinoma and cervical cancer

Early Phase 1

Comparison of fluorine-18/copper-64-labeled DOTATATE and 68Ga-DOTATATE in PET imaging of neuroendocrine tumor

RecruitingChiCTR2300072266

Department of Nuclear Medicine, First Medical Center, PLA General Hospitalneuroendocrine tumor

Start: 2023-06-07Updated: 2023-06-18

Comparison of copper-64-labeled PSMA and 68Ga-PSMA in PET imaging of prostate cancer

Active, not recruitingChiCTR2300072655

Department of Nuclear Medicine, First Medical Center, PLA General HospitalProstate cancer

Start: 2023-07-01Updated: 2023-06-26

Diagnostic efficiency of 64Cu/68Ga-TRD2206 PET/CT in patients with urothelial carcinoma and cervical cancer

RecruitingChiCTR2500099991

First Medical Center, PLA General Hospitalurothelium carcinoma and cervical cancer

Start: 2024-10-30Updated: 2025-04-07

Unknown Phase

The application of dimeric PSMA ( DPSMA ) positron imaging agent in prostate cancer

Active, not recruitingChiCTR2500099053

First Medical Center, PLA General HospitalProstate cancer

Start: 2020-03-25Updated: 2025-03-24

Related Papers

Head-to-Head comparison of [<sup>18</sup>F]AlF-NOTA-TATE and [<sup>68</sup>Ga]Ga-DOTA-TATE PET/CT in patients with neuroendocrine tumors: a prospective study.

2025-09-121 citations

Comparison of 64Cu-DOTA-PSMA-3Q and 64Cu-NOTA-PSMA-3Q utilizing NOTA and DOTA as bifunctional chelators in prostate cancer: preclinical assessment and preliminary clinical PET/CT imaging

European Journal of Nuclear Medicine and Molecular Imaging2025-02-155 citations

Real-time diagnosis of sampled lesions in targeted biopsy of prostate Cancer using a novel tracer [64Cu] Cu-DOTA-PSMA-3Q: a pilot preclinical study

European Journal of Nuclear Medicine and Molecular Imaging2024-11-304 citations